Mangione to Invoke Psychiatric Defence in Murder Trial

In this week's New York court session, the attorneys representing Luigi Mangione were briefed by Judge Gregory Carro on a psychiatric defence strategy that, if accepted by a jury, would shift a murder charge to manslaughter. The defence will claim that Mangione was in an “extreme emotional disturbance” when he fired the fatal shot at UnitedHealthcare chief executive Brian Thompson on 4 December 2024.

Mangione has pleaded not‑guilty in both the federal and state proceedings. While his federal murder and firearms charges were dismissed earlier in the year, he continues to face federal stalking indictments that could bring a maximal life‑in‑prison sentence. The state trial is scheduled to begin on 8 September, with jury selection already set for that same month.

Judge Carro agreed to unseal the court records related to the defence’s plan, making the arguments available to the public. On the day of the hearing, Mangione was present in the courtroom, though he had originally been expected to appear on an earlier date that was cancelled after a reporting error by the prosecution.

Thompson, a 50‑year‑old father of two, was shot from behind by a masked gunman while entering a Manhattan hotel for an annual investor conference. The incident has drawn national attention, and the legal proceedings are closely monitored for their implications on corporate security and violent crime.

If the psychiatric defence is upheld, Mangione could face a manslaughter conviction instead of a murder conviction, potentially reducing his sentence in the state court system. The outcome remains contingent on the jury’s assessment and the judge’s direction regarding the admissibility of psychiatric evidence.